We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

An upcoming EU-funded research project will use mobile phones to monitor trials of Ebola vaccines.
US-based non-profit organisation the Grameen Foundation aims to start deploying its Mobile Technology for Community Health (MOTECH) communication system in the second quarter of the year during upcoming clinical trials in West Africa.
The project is part of a €215 million (around US$242 million) research programme on Ebola run by the Innovative Medicines Initiative, a public-private health partnership between the European Union and Europe’s pharmaceutical industry.
MOTECH can send patients text or voice message alerts about treatments. It can also collect data for researchers on vaccine efficiency and deployment. The partners hope the software will help contain Ebola, which has killed nearly 9,000 people in West Africa.

“We will continue to measure the effectiveness of this deployment in real-time and make adjustments as needed to enhance its impact.”

Alex Counts, Grameen Foundation

“For this project, that could include sending SMS reminders to patients about vaccine boosters, as well as educational messages via voice messages to dispel beliefs that discourage vaccinations,” says Alex Counts, the CEO of the Grameen Foundation. “We could also create mobile-phone-based tools to improve the skills of local healthcare workers.”
The Innovative Medicine Initiative’s programme will initially cover around 400,000 people living in areas with high risk of Ebola infection. The foundation says that using MOTECH could yield important results about the acceptability of vaccines to patients and the feasibility of data collection to lay the groundwork for other clinical trials.
MOTECH’s most important contribution will be ensuring that patients comply with vaccine regimes, the foundation adds. “Throughout the project, we will continue to measure the effectiveness of this deployment in real-time and make adjustments as needed to enhance its impact,” Counts tells SciDev.Net.
The MOTECH system has been deployed in ten countries around the world, including Bangladesh, where it was used to detect and diagnose malaria patients in remote mountain areas. Health workers used mobile phones to report suspected infections and perform remote diagnoses.
Wasif Ali Khan, a researcher involved in the Bangladeshi roll-out of MOTECH, says the technology is useful for dispelling myths around diseases — a problem that undermines Ebola containment — thus leading to earlier and better treatment.
He adds that the use of MOTECH in Bangladesh lessened people’s reliance on local medicine men and informal drug vendors, therefore reducing the risk of inappropriate treatment.